Simulect and Icterus - a phase IV clinical study of FDA data

Summary:

Icterus is reported as a side effect among people who take Simulect (basiliximab), especially for people who are male, 50-59 old, have been taking the drug for < 1 month also take Cellcept, and have Hypercoagulation.

The phase IV clinical study analyzes which people have Icterus when taking Simulect. It is created by eHealthMe based on reports of 3,859 people who have side effects when taking Simulect from the FDA, and is updated regularly.

What is Simulect?

Simulect has active ingredients of basiliximab. eHealthMe is studying from 3,861 Simulect users. Check the latest studies of Simulect.

What is Icterus?

Icterus (yellowish pigmentation of the skin) is found to be associated with 2,137 drugs and 2,991 conditions by eHealthMe. Check the latest studies of Icterus.

On Nov, 29, 2025

3,859 people reported to have side effects when taking Simulect.
Among them, 15 people (0.39%) have Icterus.

Among these 15 people:

How long have people been on Simulect when they have Icterus? *

What is the gender of people who have Icterus when taking Simulect? *

female: 7.14 %
male: 92.86 %

What is the age of people who have Icterus when taking Simulect? *

What are other drugs people take besides Simulect? *

What are other side effects people have besides Icterus? *

Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 7 people, 46.67%
Blood Alkaline Phosphatase Increased: 5 people, 33.33%
Nausea (feeling of having an urge to vomit): 4 people, 26.67%
Diarrhea: 4 people, 26.67%
Gallstones (stone formation by bile component): 4 people, 26.67%
Gamma-Glutamyltransferase Increased: 4 people, 26.67%
Nausea And Vomiting: 4 people, 26.67%
Blood Bilirubin Increased: 4 people, 26.67%
Cholestasis (a condition where bile cannot flow from the liver to the duodenum): 4 people, 26.67%
Bile Duct Obstruction (blockage in the tubes that carry bile from the liver to the gallbladder): 4 people, 26.67%

What are the existing conditions these people have? *

Hypercoagulation (increased tendency for clotting of the blood): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Simulect and have Icterus?

- Check whether Icterus is associated with a drug or a condition (FREE)
- Predict drug outcomes for up to one year with AI (FREE)
- Get an AI agent to monitor your drugs continuously (FREE)

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Simulect:

Simulect (3,861 reports)

Icterus treatments and more:

Icterus (33,621 reports)

Browse all side effects of Simulect:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Icterus:

Icterus (2,137 drugs)

Browse all the conditions that are associated with Icterus:

Icterus (2,991 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on basiliximab (the active ingredients of Simulect) and Simulect (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.